A review on vasohibin and ocular neovascularization
Volume: 13, Issue: 6, Pages: 1004 - 1008
Published: Jun 18, 2020
Abstract
Ischemic and neovascular disease is one of the most difficult ocular diseases to deal with nowadays. Redundancy, poor visual acuity and decreased life quality are bothering patients and ophthalmologists for decades. After vascular endothelial growth factor (VEGF) was found to be a primary factor in promoting retinal angiogenesis, intravitreal injection of anti-VEGF drugs has been the first-line treatment. Whereas, some patients are refractory to...
Paper Details
Title
A review on vasohibin and ocular neovascularization
Published Date
Jun 18, 2020
Volume
13
Issue
6
Pages
1004 - 1008
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History